Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

Fernández-Sáez, EM; Losarcos, M; Becerril, S; Valentí, V; Moncada, R; Martín, M; Burrell, MA; Catalán, V; Gómez-Ambrosi, J; Mugueta, C; Colina, I; Silva, C; Escadlada, J; Frühbeck, G; Rodríguez, A

Rodríguez, A (通讯作者),Inst Invest Sanit Navarra IdiSNA, Obes & Adipobiol Grp, Pamplona, Spain.;Rodríguez, A (通讯作者),Clin Univ Navarra, Metab Res Lab, Irunlarrea 1, Pamplona 31008, Spain.

METABOLISM-CLINICAL AND EXPERIMENTAL, 2023; 147 ():